Xenon Pharmaceuticals
XENE
#3697
Rank
NZ$5.95 B
Marketcap
NZ$77.10
Share price
-1.07%
Change (1 day)
7.06%
Change (1 year)

Revenue for Xenon Pharmaceuticals (XENE)

Revenue in 2025 (TTM): NZ$13.22 Million

According to Xenon Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is NZ$12.98 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xenon Pharmaceuticals from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$13.22 M
2024 N/A
2023 N/A-100%
2022 NZ$14.85 M-44.95%
2021 NZ$26.99 M-39.45%
2020 NZ$44.57 M339.65%
2019 NZ$10.13 M
2018 N/A-100%
2017 NZ$0.43 M-83.18%
2016 NZ$2.6 M-88.56%
2015 NZ$22.75 M-37.14%
2014 NZ$36.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Coherus BioSciences
CHRS
NZ$0.14 B 1,014.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
NZ$0.32 B 2,415.56%๐Ÿ‡บ๐Ÿ‡ธ USA